Southern Cannabis Holdings (SCH) is pleased to announce that it has officially commenced operations in Australia and the United Kingdom. SCH is a multinational company that builds, integrates and operates businesses in pharmaceutical cannabis markets.
CA Clinics patient interview
We recently attended the media launch party for Southern Cannabis Holdings, which included Cannabis Access Clinics, FreshLeaf Analytics and Applied Cannabis Research.
Check it out, and make sure to subscribe to our YouTube channel for more content.
FreshLeaf Analytics, a Southern Cannabis Holdings (SCH) division, has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis.
The Southern Cannabis Holding Company’s global research house, FreshLeaf Analytics, has just released its third report monitoring the products, patients and pricing of the Australian market.
This morning the company revealed that it has received Human Research Ethics Committee (HREC) approval to conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia.